Healthcare Industry News: Pegasus Biologics
News Release - June 28, 2007
Pegasus Biologics, Inc., a Leader in Bioimplants for Orthopedic Repair, Announces New Chief Executive OfficerIRVINE, Calif.--(HSMN NewsFeed)--Pegasus Biologics, a privately held developer of unique bioimplants for soft tissue repair, and wound care for diabetic ulcers, announced today the appointment of Michael Will as Chief Executive Officer.
Keegan Harper, Chairman of the Pegasus Biologics' Board announced, "Michael Will has a long and impressive background in the medical device industry and is a strong addition to the Pegasus Biologics' organization. His years of experience and proven track record of growing medical device businesses, revenue creation, strategic leadership and team building abilities make him extremely qualified to carry Pegasus Biologics, Inc. to the next level."
"We are delighted to have Michael join our team," added France Dixon Helfer, President and Founder. "He will be an invaluable asset to us at this stage where our Company is experiencing stellar growth and robust business development opportunities. With Michael's expertise and proven track record, we anticipate further accelerating our Company's already rapid growth."
Will stated, "I am excited to join Pegasus Biologics at this opportune time. I look forward to working with the team to maximize the full potential of opportunities within our current applications in orthopedics, sports medicine, podiatry and wound care, as well as solidifying strategic relationships that will help us to greatly expand our business. I additionally look forward to the many opportunities outside of the US with our recent CE Mark approval."
Will joins Pegasus Biologics, Inc. with over 25 years in sales, marketing, operations and executive leadership experience. Most recently he was Senior Vice President of Synthes Spine following the acquisition of Spine Solutions -a pioneer in artificial disc technology, where he served as Chief Operating Officer. From 1981-2002, he was at U.S. Surgical (USS), where he held a variety of roles, including Vice President of Sales, Vice President of Marketing Programs, and General Manager of Surgical Dynamics - a wholly-owned subsidiary focused on spine and sports medicine. He will be based at the Company's headquarters in Irvine, California.
About Pegasus Biologics, Inc.
Pegasus Biologics, Inc. (Irvine, CA) is a privately held company focused on the research, development, and commercialization of next generation biologics utilizing the Company's unique and patented technologies. Additional information on the Company can be found at www.pegasusbio.com.
Source: Pegasus Biologics
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.